Israt Jahan
Research Subjects
Israt Jahan has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Zhahirul Islam
Gut Brain Axis Laboratory, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh
9 shared publications - Asaduzzaman Asad
Gut-Brain Axis Laboratory, Infectious Disease Division, icddr,b, Dhaka, Bangladesh
6 shared publications - Shoma Hayat
Gut‐Brain Axis Laboratory, Infectious Diseases Division (IDD) icddr,b Dhaka Bangladesh
6 shared publications Ruma Begum
Gut-Brain Axis Laboratory, Infectious Disease Division, icddr,b, Dhaka, Bangladesh
5 shared publicationsHubert P. Endtz
Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
4 shared publications- Md. Abu Jaher Nayeem
Gut-Brain Axis Laboratory, Infectious Disease Division, icddr,b, Dhaka, Bangladesh
3 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (10)
Transformative advances in Guillain–Barré syndrome research
The Guillain–Barré Syndrome Innovation Alliance held its inaugural meeting focused on creating treatment solutions for Guillain–Barré syndrome (GBS), an autoimmune disease increasingly recognized as a postinfectious neuropathy and the most common cause of paralysis since vaccines for polio. These collaborators, funded by the Department of War, Congressionally Directed Medical Research Programs, and the National Institute of Allergy and Infectious Diseases, span institutes/universities, including the University of Georgia, Michigan State University, Florida State University, the University of Utrecht, the International Centre for Diarrhoeal Disease Research, and the Uniformed Services University of the Health Sciences. Group efforts span biochemistry, epidemiology, immunology, medicine, microbiology, microbial ecology, glycobiology, neurology, neuroscience, pharmacology, and multiomics data science/computational biology. Our team is committed to the advancement of two core objectives: expanding understanding of biological mechanisms of GBS and developing more efficacious, targeted therapies. We are dedicated to finding alternative therapies for patients unresponsive to intravenous immunoglobulin and to creating affordable options to eliminate financial barriers to care.
- 27 October 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (10)
Open AccessTransformative advances in Guillain–Barré syndrome research
The Guillain–Barré Syndrome Innovation Alliance held its inaugural meeting focused on creating treatment solutions for Guillain–Barré syndrome (GBS), an autoimmune disease increasingly recognized as a postinfectious neuropathy and the most common cause of paralysis since vaccines for polio. These collaborators, funded by the Department of War, Congressionally Directed Medical Research Programs, and the National Institute of Allergy and Infectious Diseases, span institutes/universities, including the University of Georgia, Michigan State University, Florida State University, the University of Utrecht, the International Centre for Diarrhoeal Disease Research, and the Uniformed Services University of the Health Sciences. Group efforts span biochemistry, epidemiology, immunology, medicine, microbiology, microbial ecology, glycobiology, neurology, neuroscience, pharmacology, and multiomics data science/computational biology. Our team is committed to the advancement of two core objectives: expanding understanding of biological mechanisms of GBS and developing more efficacious, targeted therapies. We are dedicated to finding alternative therapies for patients unresponsive to intravenous immunoglobulin and to creating affordable options to eliminate financial barriers to care.
- Open Access
- 22 September 2026
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 20
Integrative Bioinformatics Analysis Reveals Convergent Immune Dysregulation in Th17 Cell Differentiation and JAK-STAT Signaling Pathways in Cytomegalovirus Infection and Guillain-Barré Syndrome
Guillain-Barré Syndrome (GBS) is a post-infectious autoimmune neuropathy and the leading cause of acute flaccid paralysis worldwide, frequently triggered by preceding infections including Campylobacter jejuni and cytomegalovirus (CMV). Unlike C. jejuni -associated GBS, the immunopathogenic mechanisms underlying CMV-associated GBS remain poorly defined. Using an integrative immunoinformatic approach, we separately analyzed disease-associated genes from DisGeNET and publicly available PBMC transcriptomic datasets from CMV-infected and GBS patients from the Gene Expression Omnibus. Differentially expressed genes (DEGs), protein–protein interaction networks, and pathway enrichment analyses were performed to identify shared immune signatures. We identified 245 common DEGs, with hub genes including TNF, IL-1β, IL-6, IL-10, TLR4, and ICAM-1. Pathway analyses revealed significant enrichment of Th17 cell differentiation, JAK–STAT signaling, cytokine–cytokine receptor interaction, and chemokine signaling in both diseases. Despite convergence on shared pathways, key immune genes were predominantly downregulated in CMV infection but upregulated in GBS, suggesting context-dependent pathway regulation across the transition from acute viral infection to post-infectious autoimmunity. These findings provide a mechanistic framework linking CMV-induced immune perturbation and autoimmune neuropathy, and highlight Th17 differentiation and JAK-STAT signaling as central dysregulated pathways in CMV-associated GBS warranting experimental validation.
- 22 September 2026
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 20
Open AccessIntegrative Bioinformatics Analysis Reveals Convergent Immune Dysregulation in Th17 Cell Differentiation and JAK-STAT Signaling Pathways in Cytomegalovirus Infection and Guillain-Barré Syndrome
Guillain-Barré Syndrome (GBS) is a post-infectious autoimmune neuropathy and the leading cause of acute flaccid paralysis worldwide, frequently triggered by preceding infections including Campylobacter jejuni and cytomegalovirus (CMV). Unlike C. jejuni -associated GBS, the immunopathogenic mechanisms underlying CMV-associated GBS remain poorly defined. Using an integrative immunoinformatic approach, we separately analyzed disease-associated genes from DisGeNET and publicly available PBMC transcriptomic datasets from CMV-infected and GBS patients from the Gene Expression Omnibus. Differentially expressed genes (DEGs), protein–protein interaction networks, and pathway enrichment analyses were performed to identify shared immune signatures. We identified 245 common DEGs, with hub genes including TNF, IL-1β, IL-6, IL-10, TLR4, and ICAM-1. Pathway analyses revealed significant enrichment of Th17 cell differentiation, JAK–STAT signaling, cytokine–cytokine receptor interaction, and chemokine signaling in both diseases. Despite convergence on shared pathways, key immune genes were predominantly downregulated in CMV infection but upregulated in GBS, suggesting context-dependent pathway regulation across the transition from acute viral infection to post-infectious autoimmunity. These findings provide a mechanistic framework linking CMV-induced immune perturbation and autoimmune neuropathy, and highlight Th17 differentiation and JAK-STAT signaling as central dysregulated pathways in CMV-associated GBS warranting experimental validation.
- Open Access
- 5 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Distinct gut microbial signatures associated with disease onset and clinical course in Guillain–Barre syndrome
- 5 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessDistinct gut microbial signatures associated with disease onset and clinical course in Guillain–Barre syndrome
- Open Access
- 5 August 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (8) , e0006225
Genomic variability of lipooligosaccharide biosynthesis locus and sequence type among Campylobacter jejuni isolated from patients with Guillain-Barré syndrome
Lipooligosaccharide (LOS) is a crucial component of the Campylobacter jejuni (C. jejuni ) cell membrane that mimics human gangliosides and can induce autoimmune neuropathies like Guillain-Barré syndrome (GBS). Approximately one in 1,000 C . jejuni infections leads to GBS, with LOS variations influencing immune response and disease induction. We aimed to investigate the sequence type and genomic variation of the LOS region of C. jejuni strains isolated from patients with GBS and enteritis. We isolated 38 GBS- and 24 enteritis-associated C. jejuni strains from Bangladesh, sequenced them on the Illumina platform, and compared their LOS regions using various bioinformatic approaches. Comparative genomic analysis between GBS-associated and enteritis-associated strains revealed that LOS classes A, B, and C were prevalent ( P = 0.0001) in GBS-associated C. jejuni strains. Sequence types ST-43 and ST-2042 and clonal complexes ST-403 cc and ST-21 cc were overrepresented in GBS compared to enteritis-associated strains. All GBS-associated strains carrying LOS class C belonged to clonal complex ST-21 cc. Nucleotide variation within the LOS region differs significantly ( P = 0.005) among GBS-associated and enteritis-associated strains. In GBS strains, phase variation (PV) within the LOS region was significantly higher ( P = 0.004). In conclusion, the predominance of GBS-associated LOS classes, characterized by class-specific nucleotide changes and elevated phase variation, may play a critical role in the pathogenesis of GBS. However, further research on integrating DNA epigenetic analysis and metabolic profiling is needed to establish the C. jejuni- specific risk factors of GBS. IMPORTANCE: The lipooligosaccharide (LOS) biosynthesis region is the most variable and virulent genomic region of Campylobacter jejuni . This study addressed the critical gap in understanding the genomic features contributing to GBS by analyzing the LOS region of C. jejuni strains from GBS and enteritis patients. Our analysis of C. jejuni isolates from GBS and enteritis cases revealed genomic variations in the sequence type and LOS region, including distinct LOS classes (A, B, and C), higher prevalence of the cst-II gene, and significant presence of phase variability among GBS-associated C. jejuni strains. The findings highlight the association of C. jejuni LOS region in the pathogenesis of GBS. In addition, the results of this study will facilitate future comparisons by identifying genomic differences in lipooligosaccharide biosynthesis and sequence types between C. jejuni strains linked to GBS. This will enhance our understanding of the genomic variation of the LOS region and their role in GBS development.
- 5 August 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (8) , e0006225
Open AccessGenomic variability of lipooligosaccharide biosynthesis locus and sequence type among Campylobacter jejuni isolated from patients with Guillain-Barré syndrome
Lipooligosaccharide (LOS) is a crucial component of the Campylobacter jejuni (C. jejuni ) cell membrane that mimics human gangliosides and can induce autoimmune neuropathies like Guillain-Barré syndrome (GBS). Approximately one in 1,000 C . jejuni infections leads to GBS, with LOS variations influencing immune response and disease induction. We aimed to investigate the sequence type and genomic variation of the LOS region of C. jejuni strains isolated from patients with GBS and enteritis. We isolated 38 GBS- and 24 enteritis-associated C. jejuni strains from Bangladesh, sequenced them on the Illumina platform, and compared their LOS regions using various bioinformatic approaches. Comparative genomic analysis between GBS-associated and enteritis-associated strains revealed that LOS classes A, B, and C were prevalent ( P = 0.0001) in GBS-associated C. jejuni strains. Sequence types ST-43 and ST-2042 and clonal complexes ST-403 cc and ST-21 cc were overrepresented in GBS compared to enteritis-associated strains. All GBS-associated strains carrying LOS class C belonged to clonal complex ST-21 cc. Nucleotide variation within the LOS region differs significantly ( P = 0.005) among GBS-associated and enteritis-associated strains. In GBS strains, phase variation (PV) within the LOS region was significantly higher ( P = 0.004). In conclusion, the predominance of GBS-associated LOS classes, characterized by class-specific nucleotide changes and elevated phase variation, may play a critical role in the pathogenesis of GBS. However, further research on integrating DNA epigenetic analysis and metabolic profiling is needed to establish the C. jejuni- specific risk factors of GBS. IMPORTANCE: The lipooligosaccharide (LOS) biosynthesis region is the most variable and virulent genomic region of Campylobacter jejuni . This study addressed the critical gap in understanding the genomic features contributing to GBS by analyzing the LOS region of C. jejuni strains from GBS and enteritis patients. Our analysis of C. jejuni isolates from GBS and enteritis cases revealed genomic variations in the sequence type and LOS region, including distinct LOS classes (A, B, and C), higher prevalence of the cst-II gene, and significant presence of phase variability among GBS-associated C. jejuni strains. The findings highlight the association of C. jejuni LOS region in the pathogenesis of GBS. In addition, the results of this study will facilitate future comparisons by identifying genomic differences in lipooligosaccharide biosynthesis and sequence types between C. jejuni strains linked to GBS. This will enhance our understanding of the genomic variation of the LOS region and their role in GBS development.
- Open Access
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0163524
Resistome phylodynamics of multidrug-resistant Shigella isolated from diarrheal patients
Multi-drug resistance (MDR) in Shigella continues to pose a significant public health challenge, particularly in developing countries. Recent advances in genomics strengthen the surveillance of MDR-pathogens and antimicrobial resistance (AMR) mediators. However, genome-based investigations into resistome dynamics in Shigella are limited, specifically in Bangladesh. Therefore, we investigated MDR- Shigella resistomes to evaluate their AMR transmission and phylodynamics. Clinical Shigella strains were screened for MDR phenotypes through susceptibility tests against 28 antibiotics from 10 different classes. Whole-genome sequencing (WGS) and bioinformatics approaches were performed to unveil the resistome dynamics: >500 global plasmid entities and >1,000 plasmid-mediated resistance gene clusters from global databases were included in this study. We identified 28 distinct antimicrobial resistance genes (ARGs) from nine antibiotic classes, with 75% originating from plasmids. Notably, two conjugative MDR plasmids included nearly all potential ARGs, conferring resistance to first-line drugs for shigellosis. Two third-generation cephalosporin-resistant [ wubC-bla CTX-M-15 -ISEcp 1 and bla TEM-1 ] and two macrolide-resistant mobile genomic islands (GIs) [ mphA-mrx-mph(R)A -IS 6100 and mphE-msrE -IS 482 -IS 6 ] had emerged in Shigella in Bangladesh. In addition, trimethoprim-aminoglycoside-streptothricin-sulfonamide-resistant dfrA1-sat1-aadA1 and aph3-dfrA14-aph6-sul2 were in conjugative plasmids in Bangladesh. The MDR plasmids and resistant GIs were phylogenetically relevant to Europe, USA, or China-derived isolates, indicating carry-over of the emerging ARGs from heavily industrialized countries and MSM-burdened (men who have sex with men) populations. The global burden of resistance GIs has increased sharply, especially after 2014. Emerging resistance mediators were most frequent (>80%) in human-associated Escherichia coli and Klebsiella pneumoniae . We infer ARGs horizontally propagate among Enteropathogens: informing treatment strategies and supporting policymakers in strengthening AMR-containment efforts utilizing the phylodynamics network. IMPORTANCE: The world is suffering from a high burden of MDR enteropathogens. Healthcare providers in low- and middle-income countries (LMICs) often face trouble finding effective drugs among the many antibiotics introduced in diarrheal treatment. Resistance-mediated drug inactivation is more rapid than the advent of new antimicrobials, leaving enteritis treatment on the edge. In Bangladesh, where one-third of users are self-prescribing antibiotics and thousands are dying due to resistance-related treatment failure, phylogenomic evidence of AMR transmission root is scarce. Therefore, investigating the resistomes of MDR- Shigella , the leading cause of diarrheal deaths in Bangladesh, is crucial. We identified several emerging resistance mediators and their phylogenetic links to global entities, which is significant for improving shigellosis treatment and enhancing AMR containment strategies. Understanding the MDR mechanism in Shigella will help physicians choose effective drugs and anticipate resistance-mediated changes in treatment approaches; the spatiotemporal phylodynamics of AMR mediators aid policymakers in setting effective checkpoints in the AMR transmission network.
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0163524
Open AccessResistome phylodynamics of multidrug-resistant Shigella isolated from diarrheal patients
Multi-drug resistance (MDR) in Shigella continues to pose a significant public health challenge, particularly in developing countries. Recent advances in genomics strengthen the surveillance of MDR-pathogens and antimicrobial resistance (AMR) mediators. However, genome-based investigations into resistome dynamics in Shigella are limited, specifically in Bangladesh. Therefore, we investigated MDR- Shigella resistomes to evaluate their AMR transmission and phylodynamics. Clinical Shigella strains were screened for MDR phenotypes through susceptibility tests against 28 antibiotics from 10 different classes. Whole-genome sequencing (WGS) and bioinformatics approaches were performed to unveil the resistome dynamics: >500 global plasmid entities and >1,000 plasmid-mediated resistance gene clusters from global databases were included in this study. We identified 28 distinct antimicrobial resistance genes (ARGs) from nine antibiotic classes, with 75% originating from plasmids. Notably, two conjugative MDR plasmids included nearly all potential ARGs, conferring resistance to first-line drugs for shigellosis. Two third-generation cephalosporin-resistant [ wubC-bla CTX-M-15 -ISEcp 1 and bla TEM-1 ] and two macrolide-resistant mobile genomic islands (GIs) [ mphA-mrx-mph(R)A -IS 6100 and mphE-msrE -IS 482 -IS 6 ] had emerged in Shigella in Bangladesh. In addition, trimethoprim-aminoglycoside-streptothricin-sulfonamide-resistant dfrA1-sat1-aadA1 and aph3-dfrA14-aph6-sul2 were in conjugative plasmids in Bangladesh. The MDR plasmids and resistant GIs were phylogenetically relevant to Europe, USA, or China-derived isolates, indicating carry-over of the emerging ARGs from heavily industrialized countries and MSM-burdened (men who have sex with men) populations. The global burden of resistance GIs has increased sharply, especially after 2014. Emerging resistance mediators were most frequent (>80%) in human-associated Escherichia coli and Klebsiella pneumoniae . We infer ARGs horizontally propagate among Enteropathogens: informing treatment strategies and supporting policymakers in strengthening AMR-containment efforts utilizing the phylodynamics network. IMPORTANCE: The world is suffering from a high burden of MDR enteropathogens. Healthcare providers in low- and middle-income countries (LMICs) often face trouble finding effective drugs among the many antibiotics introduced in diarrheal treatment. Resistance-mediated drug inactivation is more rapid than the advent of new antimicrobials, leaving enteritis treatment on the edge. In Bangladesh, where one-third of users are self-prescribing antibiotics and thousands are dying due to resistance-related treatment failure, phylogenomic evidence of AMR transmission root is scarce. Therefore, investigating the resistomes of MDR- Shigella , the leading cause of diarrheal deaths in Bangladesh, is crucial. We identified several emerging resistance mediators and their phylogenetic links to global entities, which is significant for improving shigellosis treatment and enhancing AMR containment strategies. Understanding the MDR mechanism in Shigella will help physicians choose effective drugs and anticipate resistance-mediated changes in treatment approaches; the spatiotemporal phylodynamics of AMR mediators aid policymakers in setting effective checkpoints in the AMR transmission network.
- Open Access
- 1 January 2025
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2025 (1)
Elevated Serum TGF‐ β 1 Is Linked to Guillain–Barré Syndrome Severity in Bangladeshi Patients: No Association With TGF-β1 −509C/T and +869C/T Polymorphisms
Guillain–Barré syndrome (GBS) is an autoimmune peripheral nerve disorder characterized by progressive muscle weakness. Transforming growth factor‐beta 1 (TGF‐ β 1) is a major immune‐regulating cytokine; therefore, serum concentration of TGF‐ β 1 and its genotypes may contribute to developing GBS. This study is aimed at evaluating the changes in TGF‐ β 1 serum level in GBS and investigating the association of TGF-β1 gene +869C/T and −509C/T) single‐nucleotide polymorphisms (SNPs) with GBS susceptibility and TGF‐ β 1 cytokine level. A case–control study was conducted with 200 GBS patients and 200 age‐, sex‐, and ethnicity‐matched healthy controls (HCs). Serum levels of TGF‐ β 1 and anti‐GM1 autoantibodies were assessed using enzyme‐linked immunosorbent assays. The tetra‐primer amplification refractory mutation system‐PCR was used to detect the targeted TGF-β1 gene SNPs. In this study, 79% of patients were reported with antecedent events, primarily diarrhea (44%). Overall, 89% of patients were affected with severe GBS; among them, 17% required mechanical ventilation and 21% remained functionally disabled after 6 months. TGF‐ β 1 serum levels were significantly higher in GBS patients compared to HCs ( p < 0.0001), demonstrating a cut‐off of > 414.02 ng/mL for GBS. In addition, serum levels were correlated to higher GBS‐disability scores ( r s = 0.338, p < 0.0001) and were associated with severe GBS ( p = 0.04). Elevated TGF‐ β 1 concentration was associated with poor clinical outcomes in patients at 6 months of disease onset ( p = 0.006). The TGF‐ β 1‐509 T/T genotype was more frequent in Campylobacter jejuni ‐seropositive patients compared to seronegative patients (OR = 2.87, p c = 0.04), especially in those with the axonal GBS variant (OR = 3.8, p c = 0.07). However, no significant associations were found between TGF-β1 SNPs and overall the disease susceptibility or serum TGF‐ β 1 concentration. The study concluded that elevated serum TGF‐ β 1 concentration is associated with both GBS susceptibility and clinical severity and is linked to worse functional outcomes. While the –509 T/T genotype may be linked to C. jejuni –driven axonal GBS, there was no overall polymorphism association with GBS risk or cytokine levels. These findings might be crucial in understanding and predicting disease susceptibility and severity of GBS.
- 1 January 2025
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2025 (1)
Open AccessElevated Serum TGF‐ β 1 Is Linked to Guillain–Barré Syndrome Severity in Bangladeshi Patients: No Association With TGF-β1 −509C/T and +869C/T Polymorphisms
Guillain–Barré syndrome (GBS) is an autoimmune peripheral nerve disorder characterized by progressive muscle weakness. Transforming growth factor‐beta 1 (TGF‐ β 1) is a major immune‐regulating cytokine; therefore, serum concentration of TGF‐ β 1 and its genotypes may contribute to developing GBS. This study is aimed at evaluating the changes in TGF‐ β 1 serum level in GBS and investigating the association of TGF-β1 gene +869C/T and −509C/T) single‐nucleotide polymorphisms (SNPs) with GBS susceptibility and TGF‐ β 1 cytokine level. A case–control study was conducted with 200 GBS patients and 200 age‐, sex‐, and ethnicity‐matched healthy controls (HCs). Serum levels of TGF‐ β 1 and anti‐GM1 autoantibodies were assessed using enzyme‐linked immunosorbent assays. The tetra‐primer amplification refractory mutation system‐PCR was used to detect the targeted TGF-β1 gene SNPs. In this study, 79% of patients were reported with antecedent events, primarily diarrhea (44%). Overall, 89% of patients were affected with severe GBS; among them, 17% required mechanical ventilation and 21% remained functionally disabled after 6 months. TGF‐ β 1 serum levels were significantly higher in GBS patients compared to HCs ( p < 0.0001), demonstrating a cut‐off of > 414.02 ng/mL for GBS. In addition, serum levels were correlated to higher GBS‐disability scores ( r s = 0.338, p < 0.0001) and were associated with severe GBS ( p = 0.04). Elevated TGF‐ β 1 concentration was associated with poor clinical outcomes in patients at 6 months of disease onset ( p = 0.006). The TGF‐ β 1‐509 T/T genotype was more frequent in Campylobacter jejuni ‐seropositive patients compared to seronegative patients (OR = 2.87, p c = 0.04), especially in those with the axonal GBS variant (OR = 3.8, p c = 0.07). However, no significant associations were found between TGF-β1 SNPs and overall the disease susceptibility or serum TGF‐ β 1 concentration. The study concluded that elevated serum TGF‐ β 1 concentration is associated with both GBS susceptibility and clinical severity and is linked to worse functional outcomes. While the –509 T/T genotype may be linked to C. jejuni –driven axonal GBS, there was no overall polymorphism association with GBS risk or cytokine levels. These findings might be crucial in understanding and predicting disease susceptibility and severity of GBS.
- Open Access
- 17 February 2022
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 11 (2) , e0114621
Draft Genome Sequences of Four Strains of Campylobacter jejuni Isolated from Patients with Axonal Variant of Guillain-Barré Syndrome in Bangladesh
Four Campylobacter jejuni strains (Z191005RS, Z191005SS, Z201020RS, and Z201020SS) isolated from the axonal variant of Guillain-Barré syndrome (GBS) were sequenced using Illumina technology. The average genome size was from 1.61 to 1.63 gb, with a very high coverage ranging from 654× to 758×, which facilitates the possibility of rare variant calling.
- 17 February 2022
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 11 (2) , e0114621
Open AccessDraft Genome Sequences of Four Strains of Campylobacter jejuni Isolated from Patients with Axonal Variant of Guillain-Barré Syndrome in Bangladesh
Four Campylobacter jejuni strains (Z191005RS, Z191005SS, Z201020RS, and Z201020SS) isolated from the axonal variant of Guillain-Barré syndrome (GBS) were sequenced using Illumina technology. The average genome size was from 1.61 to 1.63 gb, with a very high coverage ranging from 654× to 758×, which facilitates the possibility of rare variant calling.
- Open Access
- 29 April 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (17)
Draft Genome Sequences of Three Strains of Campylobacter jejuni Isolated from Patients with Guillain-Barré Syndrome in Bangladesh
Campylobacter jejuni is the pathogen most commonly associated with Guillain-Barré syndrome (GBS). The present work describes the draft genome sequences of 3 C. jejuni strains, BD39, BD67, and BD75, isolated from stool specimens of C. jejuni -triggered patients with GBS using Illumina technologies.
- 29 April 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (17)
Open AccessDraft Genome Sequences of Three Strains of Campylobacter jejuni Isolated from Patients with Guillain-Barré Syndrome in Bangladesh
Campylobacter jejuni is the pathogen most commonly associated with Guillain-Barré syndrome (GBS). The present work describes the draft genome sequences of 3 C. jejuni strains, BD39, BD67, and BD75, isolated from stool specimens of C. jejuni -triggered patients with GBS using Illumina technologies.
- Open Access
- 1 December 2016
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 3 (6) , e284
Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes
Objective: To characterize the patterns of autoantibodies to glycolipid complexes in a large cohort of Guillain-Barré syndrome (GBS) and control samples collected in Bangladesh using a newly developed microarray technique. Methods: Twelve commonly studied glycolipids and lipids, plus their 66 possible heteromeric complexes, totaling 78 antigens, were applied to polyvinylidene fluoride–coated slides using a microarray printer. Arrays were probed with 266 GBS and 579 control sera (2 μL per serum, diluted 1/50) and bound immunoglobulin G detected with secondary antibody. Scanned arrays were subjected to statistical analyses. Results: Measuring antibodies to single targets was 9% less sensitive than to heteromeric complex targets (49.2% vs 58.3%) without significantly affecting specificity (83.9%–85.0%). The optimal screening protocol for GBS sera comprised a panel of 10 glycolipids (4 single glycolipids GM1, GA1, GD1a, GQ1b, and their 6 heteromeric complexes), resulting in an overall assay sensitivity of 64.3% and specificity of 77.1%. Notable heteromeric targets were GM1:GD1a, GM1:GQ1b, and GA1:GD1a, in which exclusive binding to the complex was observed. Conclusions: Rationalizing the screening protocol to capture the enormous diversity of glycolipid complexes can be achieved by miniaturizing the screening platform to a microarray platform, and applying simple bioinformatics to determine optimal sensitivity and specificity of the targets. Glycolipid complexes are an important category of glycolipid antigens in autoimmune neuropathy cases that require specific analytical and bioinformatics methods for optimal detection.
- 1 December 2016
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 3 (6) , e284
Open AccessMicroarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes
Objective: To characterize the patterns of autoantibodies to glycolipid complexes in a large cohort of Guillain-Barré syndrome (GBS) and control samples collected in Bangladesh using a newly developed microarray technique. Methods: Twelve commonly studied glycolipids and lipids, plus their 66 possible heteromeric complexes, totaling 78 antigens, were applied to polyvinylidene fluoride–coated slides using a microarray printer. Arrays were probed with 266 GBS and 579 control sera (2 μL per serum, diluted 1/50) and bound immunoglobulin G detected with secondary antibody. Scanned arrays were subjected to statistical analyses. Results: Measuring antibodies to single targets was 9% less sensitive than to heteromeric complex targets (49.2% vs 58.3%) without significantly affecting specificity (83.9%–85.0%). The optimal screening protocol for GBS sera comprised a panel of 10 glycolipids (4 single glycolipids GM1, GA1, GD1a, GQ1b, and their 6 heteromeric complexes), resulting in an overall assay sensitivity of 64.3% and specificity of 77.1%. Notable heteromeric targets were GM1:GD1a, GM1:GQ1b, and GA1:GD1a, in which exclusive binding to the complex was observed. Conclusions: Rationalizing the screening protocol to capture the enormous diversity of glycolipid complexes can be achieved by miniaturizing the screening platform to a microarray platform, and applying simple bioinformatics to determine optimal sensitivity and specificity of the targets. Glycolipid complexes are an important category of glycolipid antigens in autoimmune neuropathy cases that require specific analytical and bioinformatics methods for optimal detection.
- Open Access
- 1 April 2016
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 45, 45
Guillain–Barré syndrome in Bangladesh: The role TLR4 Asp299Gly and Thr399Ile polymorphisms
- 1 April 2016
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 45, 45
Open AccessGuillain–Barré syndrome in Bangladesh: The role TLR4 Asp299Gly and Thr399Ile polymorphisms